New treatment for healing broken bones that don't heal properly
Bone-targeted polymer therapeutics for non-union fracture healing
This study is testing a new treatment that uses tiny particles to deliver a special medicine aimed at helping broken bones heal better when they haven't healed properly, offering a gentler option for people with non-union fractures.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oregon NIH-funded |
| Lab location | 1 site (Eugene, United States) |
| Project ID | NIH-10681217 on NIH RePORTER |
What this research studies
This research focuses on developing a novel therapy to improve the healing of fractures that do not heal correctly, known as non-unions. It aims to create a targeted delivery system using nanoparticles to deliver a specific drug that enhances bone regeneration while minimizing side effects. By addressing the limitations of current surgical options, this approach seeks to provide a non-invasive alternative for patients suffering from non-union fractures. The study will explore how effectively this new treatment can stimulate the body's natural healing processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have experienced non-union fractures.
Not a fit: Patients with fractures that are healing normally or those who are not eligible for treatment due to other severe health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve healing outcomes for patients with non-union fractures, potentially reducing the need for invasive surgeries.
How similar studies have performed: While the approach of using targeted nanoparticle delivery systems is innovative, similar strategies have shown promise in other areas of regenerative medicine, indicating potential for success in this application.
Where this research is happening
Eugene, United States
- University of Oregon — Eugene, United States (Active)
Researchers
- Principal investigator: Benoit, Danielle S. — University of Oregon
- Study coordinator: Benoit, Danielle S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.